Ingevity Corporation (NYSE:NGVT – Get Free Report) CEO David Li sold 5,000 shares of the stock in a transaction on Wednesday, August 12th. The stock was sold at an average price of $76.62, for a total transaction of $383,100.00. Following the sale, the chief executive officer owned 135,636 shares of the company’s stock, valued at approximately $10,392,430.32. This represents a 3.56% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Ingevity Stock Performance
NYSE NGVT traded up $1.21 during trading on Friday, reaching $76.53. The company’s stock had a trading volume of 185,864 shares, compared to its average volume of 292,661. The company has a debt-to-equity ratio of 22.52, a quick ratio of 1.15 and a current ratio of 1.61. The firm has a market cap of $2.63 billion, a price-to-earnings ratio of 52.06 and a beta of 1.16. Ingevity Corporation has a twelve month low of $45.85 and a twelve month high of $79.29. The business’s fifty day moving average price is $73.36 and its 200-day moving average price is $71.61.
Ingevity (NYSE:NGVT – Get Free Report) last announced its earnings results on Wednesday, July 29th. The company reported $1.74 earnings per share for the quarter, topping the consensus estimate of $1.33 by $0.41. Ingevity had a net margin of 4.65% and a return on equity of 284.70%. The business had revenue of $314.10 million during the quarter, compared to the consensus estimate of $312.20 million. Ingevity has set its FY 2026 guidance at 5.000-5.450 EPS. As a group, analysts anticipate that Ingevity Corporation will post 5.4 EPS for the current fiscal year.
Institutional Trading of Ingevity
Analyst Ratings Changes
A number of analysts have weighed in on NGVT shares. Weiss Ratings raised Ingevity from a “sell (d-)” rating to a “hold (c-)” rating in a research report on Friday, July 31st. Wall Street Zen cut Ingevity from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 1st. Two research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $80.00.
Read Our Latest Research Report on NGVT
Ingevity Company Profile
Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.
The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.
See Also
- Five stocks we like better than Ingevity
- Sony and TSMC’s $4.7 Billion Venture Is About More Than Camera Sensors
- Quantum Leaps: Debt-Free as AI Storage Demand Accelerates
- NVIDIA’s $500 Billion GPU Financing Deal Fuels Path Toward $270
- Sandisk’s Margins Look Like Software. Can They Last?
Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.
